2m 2m 2m 2m 2m 2m 2m
CAMP4 THERAP (CAMP)
NASDAQ
$4.32+$0.07 (+1.65%)
Price as of Sep 11, 2026 7:30 PM EDT- $266.7MMarket Cap
- 30.77%1-Year Change
- BiotechnologyIndustry
CAMP4 THERAP (CAMP)
$4.32+$0.07 (+1.65%)
CAMP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.25 | ||
Change | -$0.09 (-2.07%) | ||
Open | $4.46 | ||
High | $4.54 | ||
Low | $4.21 | ||
Previous Close | $4.34 | ||
Volume | 101,146 | ||
30-Day Average Volume | 296,616 | ||
1-Week Change | -3.63% | ||
1-Month Change | 1.92% | ||
1-Year Change | 30.77% | ||
3-Year Change | -68.20% | ||
5-Year Change | -98.36% | ||
Fundamentals | |||
Shares Outstanding | 62.8M | ||
Total Assets | $93.4M | ||
Market Cap | $266.7M | ||
Enterprise Value | $180.3M | ||
Period: QTR TTM FY | |||
Revenue | $1.8M | ||
Net Income | -$33.5M | ||
Free Cash Flow | -$12.8M | ||
EBIT | -$33.5M | ||
EBITDA | -$33.0M | ||
Net Working Capital | $70.9M | ||
EPS | -$0.58 | ||
Enterprise Value/EBITDA | -5 | ||
Enterprise Value/Revenue | 101 | ||
P/B | -385 | ||
P/E | -7 | ||
PEG | 0 | ||
Price/Free Cash Flow | -21 | ||
Price/Operating Cash Flow | -21 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 23 | ||
Last Split Date | 02/02/2024 | ||
Earnings & Revenue